Accession: openFDA-FAERS-MASLD-drugs-liver-AEs
Source / host: openFDA — openFDA (api.fda.gov)
Disease relevance: MASLD / NAFLD / NASH (category: Safety-tox, subtype: FAERS adverse events (liver-scoped))
Modality / assay: pharmacovigilance
Platform: openFDA drug/event
Organism: human
Samples: 0
Size (indexed): 26.3 KB (26931 bytes)
Access / raw: public / OPEN-processed
Download
- Source URL: https://api.fda.gov/drug/event.json
- PMIDs:
Files
| File | Size | SHA256 |
|---|---|---|
faers_resmetirom_liver_reactions.json | 1.6 KB | 016729ddb83af447… |
faers_pioglitazone_liver_reactions.json | 148 B | ac4b151563a7b8aa… |
faers_obeticholic_acid_liver_reactions.json | 403 B | accd5a56ebfb8d00… |
faers_semaglutide_liver_reactions.json | 433 B | e38e0c11dfa94bac… |
faers_vitamin_e_liver_reactions.json | 385 B | 2e656819e8849b45… |
faers_MASLD_drugs_combined.json | 23.3 KB | aa43473de0c96759… |
Index note: openFDA FAERS liver-scoped reaction slices for 5 MASLD drugs
Crawled by masld-atlas-crawler v1.0 at 2026-08-06T03:39:37Z.
About this dataset
This openFDA drug/event dataset provides single-cell gene expression from human liver samples, with disease state recorded as MASLD/NAFLD/NASH.
Analyze it in Drylab
Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:
- Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
- Normalize, select variable genes, then cluster the cells and draw a UMAP.
- Annotate clusters with marker genes and compare the cell-type mix between conditions.
- Run differential expression between cell types or samples to characterize masld/nafld/nash biology.